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Introduction
Protein kinases represent a major class of enzymes that play an important role in signal transduction pathways, regulating a number of cellular functions such as cell growth, differentiation and cell death [1, 2] . Aurora kinases are serine/threonine kinases essential for mitosis, cytokinesis and deregulated chromosome segregation [3] and are overexpressed in many malignancies, including pancreatic, colorectal, ovarian, and oesophageal cancer [4] .
In view of the critical role that kinases play in cellular environment, and their overexpression in tumour cells, enzyme kinases were considered excellent targets for anticancer therapy [5] . Several kinase inhibitors were developed and their potential against various cancers have been described during different phases of treatment [6, 7] .
Danusertib (formally PHA-739358) [8, 9] , Scheme 1A, is a new, small ATP competitive molecule that inhibits Aurora kinases in vitro and in vivo [10] . Also, danusertib binds and inhibits with high affinity (IC 50 < 0.50 µM) several other tyrosine kinases such as Abl, Ret, FGFR-1 and TrkA which are involved in the pathogenesis of a variety of cancers [11] . The cross-reactivity of danusertib with different receptor kinases has great anticancer therapeutic potential [12] , turning this drug effective for the treatment of multiple tumour models [4] .
Clinical trials for the determination of danusertib efficacy in treatment of prostate [13] , gastroenteropancreatic [14] , hepatic [15] , and haematological [16] malignancies have shown a favourable pharmacokinetic and safety profile. Despite the positive results, resistance to danusertib treatment emerged during several studies, but its ability in producing molecular complete remissions of tumours was improved using combinations with traditional antineoplastic agents [17] .
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A c c e p t e d M a n u s c r i p t 4 Being a relatively new drug, most references in the specialized literature deal with clinical studies. The crystal structure of the Abl kinase mutant in complex with danusertib has been resolved and the mechanism by which danusertib may be used to treat resistant leukaemia cells explained [18] . However, considering the importance of danusertib as a chemotherapeutic agent, suitable analytical procedures are required so that issues such as drug-drug or drug-biomolecular complex interactions can be evaluated.
Electroanalytical methods are fast, inexpensive, and the investigation of the electrochemical oxidation mechanisms of compounds has the potential for providing valuable insights into their biological redox reactions. Electroanalysis has been successfully used to determine the redox mechanism of several pharmaceutical compounds and to quantitate different types of drugs [19] [20] [21] [22] [23] [24] .
In this context, the aim of the present study is the investigation of the electron transfer properties of danusertib using a glassy carbon electrode and electrochemical techniques, cyclic, differential pulse and square wave voltammetry. In order to understand and explain danusertib redox reactions, its electrochemical behaviour was compared with chemical analogues such as imatinib mesylate, Scheme 1B, and piperazine citrate. The analytical determination of danusertib had been also carried by voltammetry and UV-VIS spectrophotometry.
Experimental

Materials and reagents
Danusertib from Selleck Chemicals, imatinib mesylate from Novartis (Portugal) and piperazine citrate from Merck were used without purification. All supporting electrolyte solutions, Table 1 , were prepared using analytical grade reagents and purified water from a A c c e p t e d M a n u s c r i p t 5 and 1 mM imatinib mesylate in ethanol and 1 mM piperazine citrate in deionised water were kept at +4 °C until further utilisation. Solutions of different concentrations of danusertib, imatinib mesylate and piperazine citrate were obtained by dilution of the appropriate volume in supporting electrolyte.
Microvolumes were measured using EP-10 and EP-100 Plus Motorized Microliter Pippettes (Rainin Instrument Co. Inc., Woburn, USA). The pH measurements were carried out with a Crison micropH 2001 pH-meter with an Ingold combined glass electrode. All experiments were done at room temperature (25±1°C).
Voltammetric parameters and electrochemical cells
Voltammetric experiments were carried out using a CompactStat.e running with IviumSoft 2.124, Ivium Technologies, The Netherlands. The measurements were carried out using a three-electrode system in a 0.5 mL one-compartment electrochemical cell. A glassy carbon (GCE, d = 1.0 mm), a Pt wire, and a Ag/AgCl (3 M KCl) were used as working, auxiliary and reference electrodes, respectively.
The experimental conditions for differential pulse voltammetry (DPV) were: pulse amplitude of 50 mV, pulse width of 100 ms and scan rate of 5 mV s -1 . For square wave voltammetry (SWV) a potential increment of 2 mV and pulse amplitude of 50 mV were always used. The frequency and consequently the effective scan rate are indicated in the text.
The GCE was polished using diamond spray, particle size 3 μm (Kemet, UK) before each electrochemical experiment. After polishing, it was rinsed thoroughly with Milli-Q water. Following this mechanical treatment, the GCE was placed in buffer supporting electrolyte and differential pulse voltammograms were recorded until a steady state baseline voltammogram was obtained. This procedure ensured very reproducible experimental results.
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UV-VIS spectrophotometry
Absorption spectra were recorded using a UV-VIS spectrophotometer SPECORD S100 from Carl Zeiss Technology with Win-Aspect software and a 10 mm quartz cuvette.
The experimental conditions for absorption spectra were: integration time 25 ms and accumulation 1000 points. All UV-VIS spectra were measured from 200 nm to 400 nm.
Acquisition and presentation of data
All differential pulse and square wave voltammograms presented were smoothed and baseline-corrected using an automatic function included in the IviumSoft version 2.124. This mathematical treatment improves the visualization and identification of peaks over the baseline without introducing any artefact, although the peak current is in some cases reduced (< 10%) relative to that of the untreated curve. Nevertheless, this mathematical treatment of the original voltammograms was used in the presentation of all experimental voltammograms for a better and clearer identification of the peaks. The values for peak current presented in all graphs were determined from the original untreated voltammograms.
Origin Pro 8.0 from OriginLab Corporation was used for the presentation of all the experimental data reported in this work.
Results and discussion
Cyclic voltammetry
The voltammetric behaviour of danusertib at a clean GCE was initially investigated in Cyclic voltammograms recorded in a solution of 50 µM danusertib in pH = 3.4
showed three consecutive anodic charge transfer reactions: peak 1 a at E p1a = +0.97 V, peak 2 a at E p2a = +1.03 V and a small peak 3 a at E p3a = +1.22 V, Fig. 1A . Reversing the scan direction, a cathodic peak appeared at E pc = +0.85 V. By recording successive voltammograms in the same solution without cleaning the GCE surface, the decrease of all peaks was due to the adsorption of danusertib oxidation products at the GCE surface, reducing the electroactive area. No additional signal was observed showing that the oxidation products of danusertib are not electroactive.
In order to clarify the origin of the cathodic peak at +0.85 V, two new experiments were carried out in the same solution always with a clean GCE surface. In the first experiment, the scan direction was inverted at +0.96 V, which corresponded to peak 1 a but before occurrence of peak 2 a . No cathodic reaction was observed in these conditions, Fig. 1A .
In a new experiment, changing the scan direction at +1.15V, i.e. after the occurrence of peak 2 a but before 3 a , the cathodic correspondent peak 2 c appeared at E p2c = +0.85 V, The effect of scan rate on the oxidation of danusertib was evaluated in pH = 7.0 (not shown). In these conditions, peaks 1 a and 2 a merged and only one anodic peak was observed.
Increasing the scan rate the peak potential shifted to more positive values. The peak current A c c e p t e d M a n u s c r i p t 8 increased but the linear relationship log I pa vs. log v with a slope of -0.75 showed that the oxidation of danusertib involves adsorption of the compound at the GCE surface. Also, an increase of the ratio between the anodic and the cathodic peak currents was observed.
Cyclic voltammograms recorded in solutions of danusertib in supporting electrolytes with different pH values showed that danusertib oxidation is pH-dependent.
Differential pulse voltammetry
The pH effect on the electrochemical oxidation of danusertib was investigated for electrolytes with 2.0 < pH < 12.0, using different voltammetric techniques. DPV allowed For electrolytes with 5.7 < pH < 9.2, only one, pH-dependent peak was observed, Fig.   2A . The width at half height of the peak (W 1/2 ) varied between 75 and 80 mV, which is higher than the theoretical value for a system that involves the transfer of 2 electrons but smaller than the value correspondent to 1 electron. The value of W 1/2 can be explained considering the overlapping of peaks 1 a and 2 a , Fig. 2B , each corresponding to the transfer of two electrons.
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For pH > 10.0, peak 1 a appeared at higher potential values than peak 2 a , Fig. 2A . In these conditions, the potential of peak 1 a was pH-independent, Fig. 2B , suggesting an oxidation mechanism that involves only the transfer of electrons after chemical deprotonation.
The value of pK a ~ 10.0 of danusertib was determined.
Consecutive DP voltammograms were recorded in solutions of different concentrations and pH values, and after the transfer of the electrode to the supporting electrolyte, Fig. 3 . A similar experiment has been carried out at pH = 5.7, Fig. 3B . On the first DP voltammogram recorded in 0.1 µM danusertib peaks 1 a and 2 a overlapped, hence one peak occurred. On the second scan in solution without cleaning the GCE surface a better visualisation of both peaks 1 a and 2 a was observed and their currents decreased.
Square wave voltammetry
In SWV the current is sampled in both positive and negative-going pulses, oxidation and reduction peaks of the electroactive compound can be obtained simultaneously, and the reversibility of the electron transfer reaction monitored by plotting the forward and backward components of the total current. At pH = 2.0, three peaks 1 a , 2 a and 3 a were observed, Fig. 4A . The forward and backward components of the total current showed peaks corresponding to oxidation at peaks 1 a and 3 a , and to oxidation and reduction at peak 2 a . This experiment confirmed that danusertib oxidation at peaks 1 a and 3 a is irreversible whereas the redox reaction at peak 2 a is reversible.
At pH =12.0, only peaks 2 a and 1 a occurred, Fig. 4B . The deconvolution of the total current showed at peak 2 a unequal values for both current and potential. This can be explained considering that danusertib oxidation at peak 2 a involve the formation of a product that undergoes homogenous chemical reaction. At the same time, the irreversibility of danusertib oxidation at peak 1 a was observed one more time.
Analytical determination
The analytical determination of danusertib was investigated by SWV and UV-VIS spectrophotometry, Fig. 5 and Table 2 . The reproducibility of these methods was evaluated by plotting different calibration curves. The relative standard deviations (R.S.D.), Table 2 , calculated from the sensitivities of three calibration curves were around 5.6 % and 0.5 % for SWV and UV-VIS procedures, respectively. It must be mentioned that each electrochemical measurement was done using a freshly polished GCE, a process that give rise to small modifications of the electrode surface area which can in turn cause variations in the oxidation currents, which was the main source of error in the electrochemical procedure described.
Oxidation mechanism
The electrochemical oxidation of danusertib in acid media showed three consecutive, Previous results have been shown that the oxidation of imatinib is irreversible and involves the formation of an oxidation product that undergoes reversible redox reactions [19, 20] .
The DP voltammogram recorded in a solution of 5 µM piperazine citrate in pH = 4.5
showed one oxidation peak at +1.23 V, Fig. 6B .
Comparing the voltammetric behaviour of danusertib and imatinib mesylate, Fig. 6A and B, and considering their chemical structures, Schemes 1A and B, an oxidation mechanism of danusertib is proposed. For pH < 10.0, the irreversible oxidation of danusertib at peak 1 a corresponds to the removal of two electrons and one proton from the amide moiety, Scheme 2A. This oxidation reaction results in a nitrenium (aminylium) cation, in agreement with previous reports on the oxidation of amides [27] [28] [29] . For pH > 10.0, the amide group undergoes chemical deprotonation and the oxidation involves only the transfer of electrons.
The oxidation of imatinib is similar, but the formation of a quinone structure [19, 20] at the aromatic ring in the vicinity of the amide group, Scheme 1B, explains the occurrence of the oxidation product observed in the solution of imatinib, Fig. 6A . In the case of danusertib, this aromatic ring is absent, Scheme 1A, and no electroactive oxidation product was observed, The voltammograms in the solution of danusertib in acid media show the reversible charge transfer reaction at peak 2 a , Fig. 4A and 6A, which does not not occur in solutions of imatinib, Fig. 6B . It is proposed that this reaction is due to the transfer of two electrons and two protons from the pyrrolo-pyrazol moiety, Scheme 2B, with the formation of an oxidation product that undergoes reaction with water in alkaline electrolytes, Fig. 4B and Scheme 2B.
For peak 3 a of danusertib, Fig. 6A and B, it is proposed that the oxidation involves the piperazine moiety. The redox behaviour of piperazine containing compounds has been previously reported [22] [23] [24] [25] [26] . Considering that in acid media piperazine moiety is protonated (pK a1 ~ 7 and pK a2 ~ 3), the electrochemical oxidation of danusertib at peak 3 a occurs with the transfer of two electrons and two protons from the nitrogen atom in the proximity of the methyl group leading to the formation of iminium cation, Scheme 2C, which is hydrolysed forming an amine derivative and formaldehyde [26] .
Conclusion
The electrochemical oxidation mechanism of the anti-cancer drug and kinase inhibitor danusertib has been studied at a glassy carbon electrode by cyclic, differential pulse and square wave voltammetry. Three consecutive, pH-dependent charge transfer reactions were M a n u s c r i p t A c c e p t e d M a n u s c r i p t M a n u s c r i p t A c c e p t e d M a n u s c r i p t Scheme 2 -Proposed oxidation mechanisms of danusertib at different electroactive groups:
A) amide at peak 1 a , B) pyrrolo-pyrazol at peak 2 a and C) piperazine at peak 3 a . 
